BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for MIRAGEN THERAPEUTICS INC:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2020-11-09 5:26 pm Purchase | 2020-10-28 | 13G | MIRAGEN THERAPEUTICS INC MGEN | BIOTECHNOLOGY VALUE FUND L P | 7,584,219 9.990% | 7,584,219 (New Position) | Filing |